RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 25 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $328,000 | – | 858,068 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,252,964 | $3,604,000 | 0.16% |
| Bison Wealth, LLC | 30,140 | $48,000 | 0.04% |
| Spark Investment Management LLC | 36,100 | $57,000 | 0.01% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 125,000 | $200,000 | 0.00% |
| Virtu KCG Holdings LLC | 41,874 | $67,000 | 0.00% |
| A.R.T. Advisors, LLC | 11,705 | $18,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 61 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 14,000 | $22,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 5 | $0 | 0.00% |
| NORTHERN TRUST CORP | 15,560 | $25,000 | 0.00% |